Literature DB >> 29491185

Mechanical circulatory support device-heart hysteretic interaction can predict left ventricular end diastolic pressure.

Brian Y Chang1, Steven P Keller2,3, Sonya S Bhavsar4, Noam Josephy1,4, Elazer R Edelman1,5.   

Abstract

The full potential of mechanical circulatory systems in the treatment of cardiogenic shock is impeded by the lack of accurate measures of cardiac function to guide clinicians in determining when to initiate and how to optimally titrate support. The left ventricular end diastolic pressure (LVEDP) is an established metric of cardiac function that refers to the pressure in the left ventricle at the end of ventricular filling and immediately before ventricular contraction. In clinical practice, LVEDP is typically only inferred from, and poorly correlates with, the pulmonary capillary wedge pressure (PCWP). We leveraged the position of an indwelling percutaneous ventricular assist device and advanced data analysis methods to obtain LVEDP from the hysteretic operating metrics of the device. We validated our hysteresis-derived LVEDP measurement using mock flow loops, an animal model of cardiac dysfunction, and data from a patient in cardiogenic shock to show greater measurement precision and correlation with actual pressures than traditional inferences via PCWP. Delineation of the nonlinear relationship between device and heart adds insight into the interaction between ventricular support devices and the native heart, paving the way for continuous assessment of underlying cardiac state, metrics of cardiac function, potential closed-loop automated control, and rational design of future innovations in mechanical circulatory support systems.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Year:  2018        PMID: 29491185      PMCID: PMC6530904          DOI: 10.1126/scitranslmed.aao2980

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  30 in total

1.  Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment.

Authors:  Wakkas Tayara; Randall C Starling; Mohamad H Yamani; Oussama Wazni; Fuad Jubran; Nicholas Smedira
Journal:  J Heart Lung Transplant       Date:  2006-03-30       Impact factor: 10.247

Review 2.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 3.  Method agreement analysis: a review of correct methodology.

Authors:  P F Watson; A Petrie
Journal:  Theriogenology       Date:  2010-06       Impact factor: 2.740

4.  Use of motor current in flow rate measurement for the magnetically suspended centrifugal blood pump.

Authors:  T Tsukiya; T Akamatsu; K Nishimura; T Yamada; T Nakazeki
Journal:  Artif Organs       Date:  1997-05       Impact factor: 3.094

5.  Left ventricular support by catheter-mounted axial flow pump reduces infarct size.

Authors:  Bart Meyns; Jarek Stolinski; Veerle Leunens; Erik Verbeken; Willem Flameng
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

6.  Practical sources of error in measuring pulmonary artery occlusion pressure: a study in participants of a special intensivist training program of The Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI).

Authors:  I Parviainen; S M Jakob; M Suistomaa; J Takala
Journal:  Acta Anaesthesiol Scand       Date:  2006-05       Impact factor: 2.105

7.  Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.

Authors:  John J Ryan; Jonathan D Rich; Thejasvi Thiruvoipati; Rajiv Swamy; Gene H Kim; Stuart Rich
Journal:  Am Heart J       Date:  2012-04       Impact factor: 4.749

Review 8.  Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.

Authors:  Jin M Cheng; Corstiaan A den Uil; Sanne E Hoeks; Martin van der Ent; Lucia S D Jewbali; Ron T van Domburg; Patrick W Serruys
Journal:  Eur Heart J       Date:  2009-07-18       Impact factor: 29.983

9.  Obituary: pulmonary artery catheter 1970 to 2013.

Authors:  Paul E Marik
Journal:  Ann Intensive Care       Date:  2013-11-28       Impact factor: 6.925

10.  Myocardial recovery during mechanical circulatory support: long-term outcome and elective ventricular assist device implantation to promote recovery as a treatment goal.

Authors:  Michael Dandel; Roland Hetzer
Journal:  Heart Lung Vessel       Date:  2015
View more
  4 in total

1.  Dynamic Modulation of Device-Arterial Coupling to Determine Cardiac Output and Vascular Resistance.

Authors:  Steven P Keller; Brian Y Chang; Qing Tan; Zhengyang Zhang; Ahmad El Katerji; Elazer R Edelman
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

2.  A Scalable Approach to Determine Intracardiac Pressure From Mechanical Circulatory Support Device Signals.

Authors:  Brian Y Chang; Christian Moyer; Ahmad El Katerji; Steven P Keller; Elazer R Edelman
Journal:  IEEE Trans Biomed Eng       Date:  2021-02-18       Impact factor: 4.538

3.  Hysteretic device characteristics indicate cardiac contractile state for guiding mechanical circulatory support device use.

Authors:  Brian Y Chang; Zhengyang Zhang; Steven P Keller; Elazer R Edelman; Kimberly Feng; Noam Josephy
Journal:  Intensive Care Med Exp       Date:  2021-12-20

4.  Increased and continuous coronary arterial flow was induced by LV uncoupling condition using combined treatment of a microaxial heart pump and venoarterial extracorporeal membrane oxygenation.

Authors:  Motoko Kametani; Masahiro Yamada; Yoko Horibata; Tomohiro Sakamoto; Takashi Unoki
Journal:  Physiol Rep       Date:  2021-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.